HIGHLIGHTS OF PRESCRIBING INFORMATION . . . - ARIKAYCE Instruct patients to read the Instructions for Use before starting ARIKAYCE Instruct patients to only use the Lamira® Nebulizer System to administer ARIKAYCE Advise the patient or caregiver not to use the Lamira Nebulizer System with any other medicine
Find out if ARIKAYCE is right for you Find out if ARIKAYCE® is right for you See Prescribing and Safety Information about ARIKAYCE, including Boxed Warnings
About ARIKAYCE® (amikacin liposome inhalation suspension) ARIKAYCE is used in combination with multidrug therapy for adults who still test positive for MAC lung disease after at least 6 months on multidrug treatment alone ARIKAYCE was approved by FDA using the Limited Population pathway